Related Experiment Videos
Aldosterone and renal injury
1Department of Pharmacology, Kagawa Medical University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan. akira@kms.ac.jp
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|July 28, 2004
Summary
Aldosterone causes kidney damage by increasing oxidative stress and activating specific cell signaling pathways. Blocking these pathways with medications like eplerenone or antioxidants prevents this damage.
Area of Science:
- Nephrology
- Cell Biology
- Biochemistry
Background:
- Aldosterone is implicated in renal injury progression.
- Glomerular injury involves proteinuria, cell proliferation, and matrix expansion.
Purpose of the Study:
- To investigate the mechanisms of aldosterone-induced renal injury.
- To explore the role of reactive oxygen species (ROS) and mitogen-activated protein kinase (MAPK) pathways.
Main Methods:
- Rats received chronic aldosterone and NaCl treatment.
- Evaluated effects of mineralocorticoid receptor antagonist (eplerenone) and antioxidant (tempol).
- In vitro studies on rat mesangial cells.
Main Results:
- Aldosterone induced severe proteinuria and glomerular injury in rats.
- Increased renal NAD(P)H oxidase, ROS generation, and MAPK activation were observed.
- Eplerenone and tempol ameliorated injury by reducing ROS and MAPK activity.
- Aldosterone activated MAPK and induced proliferation in mesangial cells.
Conclusions:
- Aldosterone-induced glomerular injury is mediated by redox-sensitive MAPK activation.
- Mineralocorticoid receptors in mesangial cells are key targets.
- Aldosterone directly contributes to glomerular injury progression.